AparnaBio has secured intellectual property covering its NanoElectroPlexTM delivery platform and antifungal applications of NanoElectroPlexTM components.  We continue to build our intellectual property portfolio by ongoing invention, filing patent applications , and prosecution of existing patent applications.

We welcome opportunities to license this technology to deliver novel therapeutic entities owned by potential partners and to create new patentable therapeutic formulations based on existing chemical entities.